image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Sigmaroc

June 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 68p
Once again SigmaRoc has rubbished its lowly valuation with its Q1 trading update stating like-for-like revenues 19% ahead of the same period in 2019 at £111.2m. Customer demand has remained strong across all products and regions with the group benefiting from ongoing efficiency and commercial initiatives. Nordkalk, its record acquisition, has traded well and in line in spite of some specific customer disruption. Interestingly, it said demand for construction remained strong across the UK infrastructure, housebuilding and RMI markets. Benelux remained strong while more generally concrete and aggregate sales have also been strong and ahead of expectations at some sites. Trading on a prospective PE of just 10.3, the shares a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author